FMNL3 expression is reported to promote migration and invasion of cancer cells and predicts clinical outcome in different solid cancers such as colorectal carcinoma [28, 49], squamous cell carcinoma of the tongue [30], and melanoma [50]. Here, FMNL3 is linked to colorectal carcinoma.